PRESS RELEASE published on 02/20/2026 at 18:36, 2 months 23 days ago EQS-Adhoc: innoscripta SE: Management Board Proposes Dividend of EUR 4.00 per Share innoscripta SE Management Board proposes a dividend of EUR 4.00 per share for the past financial year, prioritizing shareholder participation in the company's success Shareholders Financial Year Dividend Innoscripta SE EUR 4.00
BRIEF published on 01/27/2026 at 13:19, 3 months 20 days ago Innoscripta SE annonce de solides résultats préliminaires pour son exercice 2025 EBIT Résultats Préliminaires Croissance Des Revenus Logiciel Basé Sur Le Cloud Incitations Fiscales À La R&D
BRIEF published on 01/27/2026 at 13:19, 3 months 20 days ago Innoscripta SE Reports Strong Preliminary Annual Results for 2025 Revenue Growth EBIT Preliminary Results Cloud-based Software R&D Tax Incentives
PRESS RELEASE published on 01/27/2026 at 13:14, 3 months 20 days ago innoscripta SE publishes Preliminary Annual Results for 2025 innoscripta SE publishes Preliminary Annual Results for 2025 with Group revenue of EUR 103.4 million and EBIT of EUR 63.4 million. Company shows stable growth trajectory and strong demand for R&D tax solutions Preliminary Annual Results Growth Trajectory 2025 Financial Year Innoscripta SE R&D Tax Incentives
BRIEF published on 01/27/2026 at 08:52, 3 months 20 days ago Innoscripta SE Reports Increased Revenue in 2025 Preliminary Results Revenue Growth Cloud-based Software 2025 Financial Results Innoscripta SE R&D Tax Incentives
BRIEF published on 01/27/2026 at 08:52, 3 months 20 days ago Innoscripta SE annonce une hausse de son chiffre d'affaires pour 2025 (résultats préliminaires). Croissance Des Revenus Logiciel Basé Sur Le Cloud Résultats Financiers 2025 Innoscripta SE Incitations Fiscales À La R&D
PRESS RELEASE published on 01/27/2026 at 08:47, 3 months 20 days ago EQS-Adhoc: innoscripta SE: Preliminary Annual Results for 2025 innoscripta SE publishes preliminary unaudited results for 2025, expecting improved operating performance with Group revenue not less than EUR 103.4 million and Group EBIT not less than EUR 63.4 million Financial Performance Annual Results Preliminary 2025 Innoscripta SE
BRIEF published on 11/03/2025 at 09:06, 6 months 13 days ago Innoscripta SE enregistre une forte croissance au troisième trimestre 2025 Croissance Des Revenus Innoscripta SE Résultats Du Troisième Trimestre 2025 Incitations Fiscales À La R&D Optimisation Numérique
BRIEF published on 11/03/2025 at 09:06, 6 months 13 days ago Innoscripta SE Achieves Robust Growth in Q3 2025 Revenue Growth Q3 2025 Results Innoscripta SE R&D Tax Incentives Digital Optimization
PRESS RELEASE published on 11/03/2025 at 09:01, 6 months 13 days ago innoscripta reports successful third quarter of 2025 innoscripta SE reports strong financial performance in Q3 2025 with significant revenue and EBIT growth. The company attributes success to digital process optimization and platform development Revenue Growth Financial Performance Q3 2025 Innoscripta SE Digital Processes
Published on 05/16/2026 at 01:15, 14 hours 56 minutes ago Findev Inc. Announces a New Member of the Board of Directors
Published on 05/16/2026 at 00:00, 16 hours 11 minutes ago Onco-Innovations Strengthens Quality Testing for Lead PNKP Inhibitor Drug Candidate
Published on 05/15/2026 at 23:10, 17 hours 1 minute ago Golden Minerals Reports First Quarter 2026 Financial Results
Published on 05/15/2026 at 23:00, 17 hours 11 minutes ago Jericho Energy Ventures Announces Transition to Semi-Annual Reporting to Enhance Efficiency
Published on 05/16/2026 at 16:08, 3 minutes ago The publication of the audited financial statements for 2025 will be postponed to 12 June 2026 – management does not expect any significant changes to the figures already published
Published on 05/15/2026 at 20:10, 20 hours 1 minute ago CPIPG Communication Concerning Voluntary Offer on NEXT RE Shares – Provisional Results Announcement
Published on 05/15/2026 at 18:10, 22 hours 1 minute ago Virtual Science AI launches first AI-driven competitor activity tracking platform to support pharma asset launch success
Published on 05/15/2026 at 15:08, 1 day 1 hour ago Notice of exercise of early redemption option of the subordinated note ISIN : FR0010203026
Published on 05/15/2026 at 15:00, 1 day 1 hour ago Exercice de l’option de remboursement de l'instrument subordonné FR0010203026
Published on 05/15/2026 at 10:09, 1 day 6 hours ago Groupe Crit : Modalités de mise à disposition des documents préparatoires à l’Assemblée Générale Mixte du 05 juin 2026.
Published on 05/14/2026 at 09:03, 2 days 7 hours ago Coup d'envoi pour les carrières dans l'esport : 65% de la population mondiale réclame plus de formations et de parcours professionnels pour le jeu vidéo de compétition
Published on 05/13/2026 at 18:02, 2 days 22 hours ago ALTAREA : Assemblée Générale Mixte du 4 juin 2026 MODALITES DE MISE A DISPOSITION DES DOCUMENTS PREPARATOIRES
